<DOC>
	<DOCNO>NCT01806584</DOCNO>
	<brief_summary>A study evaluate efficacy SRM003 treatment versus participate site ' standard practice treatment extend duration primary patency arteriovenous graft surgery subject end-stage renal disease . It hypothesize place outside blood vessel , seed SRM003 gelatin matrix contain endothelial cell provide continuous supply multiple growth regulatory compound underlie cell within blood vessel , protected effect blood flow vessel ( ) complication result direct contact point injury .</brief_summary>
	<brief_title>An Efficacy Safety Study SRM003 Treatment Subjects Undergoing Placement Arteriovenous Graft Facilitate Hemodialysis Access</brief_title>
	<detailed_description />
	<criteria>1 . Subject must 18 year age old time sign date informed consent ( upper age limit ) , male female . 2 . Subject child bear potential must agree use adequate contraception 6 month randomization . 3 . Subject must currently undergo hemodialysis anticipate start hemodialysis must require new permanent prosthetic expand polytetrafluoroethylene AVG place upper extremity . 4 . Subject must life expectancy least 78 week randomization . 5 . Subject must able understand willing complete study requirement . 1 . Subject currently active organ transplant list decease donor undergoing assessment expect place active organ bone marrow transplant list within next 78 week surgery , expect receive living donor organ bone marrow within next 78 week unwilling change transplant list status `` hold '' 3 month randomization . 2 . Subject 3 access placement surgery ( defined new access , revision ) target limb . 3 . Subject medical condition disease may cause noncompliance protocol 4 . Subject know allergy bovine/porcine product collagen/gelatin product . 5 . Subject history intravenous drug use within 6 month prior screen 6 . Subject morbidly obese , define body mass index &gt; 40 . 7 . Pregnant nursing woman , plan become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Vascular Injury</keyword>
	<keyword>Arteriovenous Graft Surgery</keyword>
	<keyword>Hemodialysis Access</keyword>
</DOC>